Surgical treatment of myomas can have a positive effect on the tome until ongoing pregnancy and decrease the risk of premature birth and miscarriages, but is depended on number, localization, size, and type of myoma.
ID
Bron
Verkorte titel
Aandoening
myomas (fibroids)
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Time until live birth
Achtergrond van het onderzoek
Patients with asymptomatic myomas have a reduced risk of spontaneous pregnancy and an increased risk of premature birth and miscarriages. However, the extent of this effect is still insufficiently known, because the literature often does not include the type, number and localization of the myoma(s). Surgical treatment of myomas are frequently performed to treat gynecological complaints and/or improve pregnancy outcomes. The long-term outcomes of these interventions have not been sufficiently investigated with regard to the reproductive outcomes. These results are important for counseling patients considering such an intervention, but also for setting up a future (randomized) study.
The primary objective is to study pregnancy outcomes in patients with asymptomatic myomas without further interventions related to spontaneous pregnancy and an increased risk of premature birth and miscarriages. We want to see if number, localization, size, and type of myoma influences these outcomes. We want to investigate the same in women who have had a myoma treatment. We want to look both at women who have had surgical treatment on the myomas to promote fertility outcomes and also at women who received this from gynecological complaints.
Doel van het onderzoek
Surgical treatment of myomas can have a positive effect on the tome until ongoing pregnancy and decrease the risk of premature birth and miscarriages, but is depended on number, localization, size, and type of myoma.
Onderzoeksopzet
One survey with questions about complaints, pregnancy and treatment of myomas.
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Patients that visited the VUmc, Amsterdam UMC, with myomas between 2004-2018.
Age at visitation between 18 and 45.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Patients that visited the VUmc, Amsterdam UMC, with myomas before 2004 or after 2018.
Age at visitation between <18 or >45
Patients with intrauterine abnormalities of the uterine cavity other than myomas or endometrial polyps. Such as congenital uterine abnormalities, uterine septum, dominant adenomyosis, malignancies, dominant intrauterine adhesions/Asherman syndrome.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Toelichting
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL7990 |
Ander register | MEC Amsterdam : protocol number 2019.225 |